# Rivaroxaban

NDC: 50228-513
Generic name: Rivaroxaban
Labeler / Manufacturer: ScieGen pharmaceuticals,Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20250804

FDA application: ANDA218117

## Active ingredients

- RIVAROXABAN: 2.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50228-513"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50228-513
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3b53cebf-946c-b82b-e063-6394a90a5da7